IBB
- iShares Biotechnology ETFKey Information
| Earliest date | 2001-02-12 |
| Exchange | NASDAQ |
| Instrument Type | ETF |
| MIC Code | XNMS |
| Country | United States |
ETF Information
| Fund Provider | BlackRock |
| Index | ICE Biotechnology Index |
| Expense Ratio | 0.45% |
| Number Of Holdings | 211 |
| Inception Date | 2001-02-05 |
| Asset Class | Equity |
| Currency | USD |
| Listing | US-listed |
| Sector | Healthcare |
| Investment Style | Growth |
| Non-leveraged | Non-leveraged |
About IBB
The iShares Biotechnology ETF provides exposure to the biotechnology sub-sector of the health care industry, investing in a diversified portfolio of over 200 stocks. The fund focuses on U.S. biotechnology companies, with a smaller allocation to international firms, and employs a tiered weighting scheme. It offers a multi-cap approach, investing in large, mid, and small-cap stocks, making it a comprehensive option for investors seeking biotech exposure.